These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19252247)

  • 1. [Efficacy of new biologics on bone destruction in rheumatoid arthritis].
    Kazuyoshi S; Tanaka Y
    Clin Calcium; 2009 Mar; 19(3):372-80. PubMed ID: 19252247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Paradigm shift in the treatment of rheumatoid arthritis by biologics].
    Tanaka Y
    Rinsho Byori; 2008 Apr; 56(4):309-15. PubMed ID: 18516965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists.
    Isaacs JD
    Expert Opin Biol Ther; 2009 Dec; 9(12):1463-75. PubMed ID: 19916731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do we need new treatment that goes beyond tumor necrosis factor blockers for rheumatoid arthritis?
    Voll RE; Kalden JR
    Ann N Y Acad Sci; 2005 Jun; 1051():799-810. PubMed ID: 16127017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Targeting CD20 in rheumatoid arthritis].
    Saito K; Tanaka Y
    Nihon Rinsho; 2007 Jul; 65(7):1243-9. PubMed ID: 17642239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid arthritis: beyond tumor necrosis factor-alpha antagonists, B cell depletion, and T cell blockade.
    Manadan AM; Block JA
    Am J Ther; 2008; 15(1):53-8. PubMed ID: 18223354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the place of recently approved T cell-targeted and B cell-targeted therapies in the treatment of rheumatoid arthritis? Lessons from global clinical trials.
    Smolen JS
    J Rheumatol Suppl; 2007 Jul; 79():15-20. PubMed ID: 17611974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent progress in clinical trials for rheumatic diseases].
    Tanaka Y
    Nihon Rinsho; 2009 Mar; 67(3):619-25. PubMed ID: 19280942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies after the failure of the first anti-tumor necrosis factor alpha agent in rheumatoid arthritis.
    Papagoras C; Voulgari PV; Drosos AA
    Autoimmun Rev; 2010 Jun; 9(8):574-82. PubMed ID: 20433955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.
    Sherrer Y
    Curr Med Res Opin; 2008 Aug; 24(8):2283-94. PubMed ID: 18590608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biologics: current therapeutic strategies for rheumatoid arthritis].
    Tanaka Y
    Nihon Rinsho; 2007 Jul; 65(7):1179-84. PubMed ID: 17642229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biological agents].
    Amano K
    Nihon Rinsho; 2009 Mar; 67(3):593-8. PubMed ID: 19280938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].
    Yukawa N; Mimori T
    Clin Calcium; 2007 Apr; 17(4):569-76. PubMed ID: 17404487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indications and efficacy of biologics in inflammatory arthritis].
    Combe B
    Bull Acad Natl Med; 2012 Oct; 196(7):1279-92; discussion 1293. PubMed ID: 23815014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent topics on new biological agents for treatment of rheumatoid arthritis].
    Saito K; Tanaka Y
    Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2418-23. PubMed ID: 19149039
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeted therapy in rheumatoid arthritis.
    Köller MD
    Wien Med Wochenschr; 2006 Jan; 156(1-2):53-60. PubMed ID: 16465614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytokines in bone diseases. Anti-cytokine therapies for bone and joint diseases].
    Tanaka Y
    Clin Calcium; 2010 Oct; 20(10):1545-52. PubMed ID: 20890038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapies for treatment of rheumatoid arthritis.
    Smolen JS; Aletaha D; Koeller M; Weisman MH; Emery P
    Lancet; 2007 Dec; 370(9602):1861-74. PubMed ID: 17570481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective costimulation modulation with abatacept: a look at quality-of-life outcomes in patients with rheumatoid arthritis.
    Shergy WJ
    Semin Arthritis Rheum; 2009 Jun; 38(6):434-43. PubMed ID: 18538830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.